Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (431-440 of 776) with videos related to

Pageof 78
Sort By:
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
BMC Bioinformatics|December 19, 2014
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's diseasePiers Johnson, Luke Vandewater, William Wilson, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
Journal of the Neurological Sciences|October 6, 2022
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressorsDhamidhu Eratne, Michael Keem, Courtney Lewis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortiumAlden L Gross, Jason J Hassenstab, Sterling C Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 8, 2025
The role of diet in moderating the relationship between symptoms of depression and brain amyloid loadHilal Salim Said Al Shamsi, Samantha L Gardener, Stephanie R Rainey-Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's diseaseSteven Ng, Victor L Villemagne, Sam Berlangieri, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's DiseaseYen Ying Lim, Paul Maruff, Naoki Kaneko, et al.
International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 78

Showing results (431-440 of 776) with videos related to

Sort By:
Pageof 78
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
BMC Bioinformatics|December 19, 2014
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's diseasePiers Johnson, Luke Vandewater, William Wilson, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
Journal of the Neurological Sciences|October 6, 2022
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressorsDhamidhu Eratne, Michael Keem, Courtney Lewis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortiumAlden L Gross, Jason J Hassenstab, Sterling C Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 8, 2025
The role of diet in moderating the relationship between symptoms of depression and brain amyloid loadHilal Salim Said Al Shamsi, Samantha L Gardener, Stephanie R Rainey-Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's diseaseSteven Ng, Victor L Villemagne, Sam Berlangieri, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's DiseaseYen Ying Lim, Paul Maruff, Naoki Kaneko, et al.
International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 78